Location History:
- Wallbach, CH (2006)
- Basel, CH (2005 - 2009)
- Binningen, CH (2009)
Company Filing History:
Years Active: 2005-2009
Title: Jürg Zimmermann: Innovator in Pharmaceutical Chemistry
Introduction
Jürg Zimmermann is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
Zimmermann's latest patents include the development of N-oxides of N-phenyl-2-pyrimidine-amine derivatives. This invention relates to derivatives where at least one nitrogen atom carries an oxygen atom, forming the corresponding N-oxides. These compounds are crucial for the preparation of pharmaceutical compositions aimed at treating warm-blooded animals, including humans. Another significant patent involves a new crystalline form of a N-phenyl-2-pyrimidineamine derivative, which is used in tumor therapy. This invention details processes for its manufacture and its potential applications in medical treatments.
Career Highlights
Jürg Zimmermann is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on the development of innovative pharmaceutical solutions that address critical health challenges.
Collaborations
Throughout his career, Zimmermann has collaborated with esteemed colleagues such as Bertrand Sutter and Hans Michael Bürger. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Jürg Zimmermann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in therapeutic treatments.